• Medicine Supply Notification: Estriol (Imvaggis® ) 0.03mg pessary

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estriol (Imvaggis®) 0.03mg pessary. MSN/2023/041 Tier 2 – medium impact Date of issue 6th April 2023 Estriol (Imvaggis®) 0.03mg pessary is out of stock until mid-late May 2023 Alternative estriol vaginal products remain available, as does estradiol 10mcg vaginal tablets, and

    Read more
  • Medicine Supply Notification: Oxycodone Hydrochloride 5mg/5ml Oral Solution

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxycodone Hydrochloride 5mg/5ml Oral Solution. MSN/2023/042 Tier 2 – medium impact Date of issue 6th April 2023 Wockhardt is out of stock oxycodone 5mg/5ml oral solution until end of June 2023. Oxycodone 5mg/5ml oral solution from other manufacturers remains available but

    Read more
  • Two SSPs issued for Clarithromycin oral suspensions

    In response to a significant ongoing disruption to the supply of Clarithromycin 125mg/5ml and 250mg/5ml oral suspension, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 6 April 2023, SSP053 and SSP054 provides for the following: SSP053 – for every 5ml of Clarithromycin 125mg/5ml oral suspension,

    Read more
  • PQS: NHSE publishes 2021/22 anticoagulant audit report

    NHS England (NHSE) has published a report on the anticoagulant audit* from the 2021/22 Pharmacy Quality Scheme (PQS). 9,303 community pharmacies participated in the anticoagulant audit and data was submitted for 131,526 patients. Pharmacy teams provided advice and made significant clinical intervention, preventing potential harm, for patients at increased risk of harm 33,173 times throughout

    Read more
  • ICS Review highlights pharmacy workforce issues

    The recruitment of pharmacists in Primary Care Networks (PCNs) has exacerbated a general shortage of pharmacists, says an independent review of Integrated Care Systems (ICSs) published today. The review, Rt Hon Patricia Hewitt, set out to consider the oversight and governance of ICS in England and the NHS targets and priorities for which Integrated Care

    Read more
  • Directions updated for Hypertension Case-Finding Service and SCS

    Pharmacy technicians are now able to perform blood pressure checks as part of the Hypertension Case-Finding Service and deliver the Smoking Cessation Service (SCS). The Drug Tariff has been amended, where necessary, to reflect this and includes the amendments to The Pharmaceutical Services (Advanced and Enhanced Services) (Amendment) (England) Directions 2023. The service specifications for

    Read more
  • PSNC publishes TAPR Progress Report

    PSNC is continuing to make progress on addressing the Review Steering Group (RSG) proposals and has today published some resources to update contractors and LPCs on this work. PSNC is taking forward the RSG proposals directed at the Committee through its Transforming Pharmacy Representation (TAPR) work programme. The resources published include an update on the Transforming Pharmacy

    Read more
  • 2023 PSNC Election: West Midlands result and CCA nominees

    Voting has now closed in the ballot for the West Midlands Regional Representative on PSNC (soon to be known as Community Pharmacy England), and the Company Chemists’ Association (CCA) has nominated its representatives.   West Midlands Regional Representative Completed voting forms received by the close of voting (12 noon on Friday 31st March 2023) have

    Read more
  • EpiPen reimbursement price redetermined for March 2023

    Following representations by PSNC on behalf of contractors the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for EpiPen preparations for March 2023 to reflect an increase in their NHS list price. On 1st March the list price of EpiPen preparations were increased by the manufacturer Viatris. DHSC have granted the following

    Read more
  • March 2023 Price Concessions Final Update

    The Department of Health and Social Care (DHSC) has today (31/03/2023) granted the following final list of price concessions for March 2023. Drug Pack size Price concession Chlorphenamine 2mg/5ml oral solution 150 £3.72 Co-amoxiclav 250mg/125mg tablets 21 £2.94 Duloxetine 60mg gastro-resistant capsules 28 £3.84 Fusidic acid 1% modified-release eye drops 5 £31.41 Ivabradine 2.5mg tablets 56

    Read more